Prevalence of conventional cardiovascular risk factors in the Great Tunis population;Prévalence des facteurs de risque cardiovasculaires conventionnels dans la population du Grand Tunis

Revue d'Epidemiologie et de Sante Publique

Volumn 57, Issue 2, 2009, Pages 87-92

  Elasmi, M ^a   Feki, M ^a   Sanhaji, H ^a   Jemaa, R ^a   Haj Taeib, S ^a   Omar, S ^a   Mebazaa, A ^a   El Ati, J ^a   Hsairi, M ^a   Kaabachi, N ^a  

^a LA RABTA HOSPITAL   (Tunisia)

Author keywords

Abdominal obesity; Cardiovascular risk factors; Diabetes mellitus; Dyslipemia; Hypertension; Smoking

Indexed keywords

ABDOMINAL FAT; ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CIGARETTE SMOKING; DIABETES MELLITUS; DIETARY INTAKE; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; OBESITY; PREVALENCE; RISK FACTOR; RISK REDUCTION; SEX DIFFERENCE; TUNISIA; URBAN RURAL DIFFERENCE;

ADULT; AGED; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DATA INTERPRETATION, STATISTICAL; DIABETES MELLITUS; DYSLIPIDEMIAS; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OBESITY; PREVALENCE; RISK FACTORS; RURAL POPULATION; SEX FACTORS; SMOKING; TUNISIA; URBAN POPULATION;

EID: 64849115261     PISSN: 03987620     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.respe.2008.12.010     Document Type: Article

References (53)

1. Organisation mondiale de santé. Rapport sur la santé dans le monde : pour un réel changement, Genève. OMS 1999:15-31.
2. Husten L. Global epidemic of cardiovascular disease predicted. Lancet 352 (1998) 1530
3. Murray C.J., and Lopez A.D. Mortality by cause for eight regions of the world: global burden of disease study. Lancet 3 (1997) 1269-1276
4. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo J.L., et al. The National High Blood Pressure Education Program Coordinating Committee. The seventh report of the Joint National Committee on Prevention, Detection. Evaluation and treatment of high blood pressure; the JNC 7 report. JAMA 289 (2003) 2560-2572
5. Expert Committee on the diagnosis and classification of diabetes mellitus. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997;20:1183-97.
6. Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation and treatment of high blood cholesterol in adult (Adult Treatment Panel III). JAMA 2001;285:2486-97.
7. The sixth report of the joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997;157:2413-46.
8. Ben Romdhane H., Bougatef S., Skhiri H., Gharbi D., Kafsi M.N., Belhani A., et al. Le registre des maladies coronaires en Tunisie : organisation et premiers résultats. Rev Epidemiol Sante Publique 52 (2004) 558-564
9. Ben Romdhane H. Les cardiopathies ischémiques, l'épidémie et ses déterminants. Vol 1 : les facteurs de risque (2001), Institut national de santé publique, Tunis p 317
10. Ben Romdhane H., Haouala H., Belhani A., Drissa H., Kafsi N., Boujnah R., et al. La transition épidémiologique, ses déterminants et son impact sur les systèmes de santé à travers l'analyse de la tendance des maladies cardiovasculaires en Tunisie. Tun Med 83 (2005) 1-7
11. Lihioui M., Boughzala E., Ben Farhat M., Ammar H., Chaouech A., Jemaa R., et al. Distribution des facteurs de risque cardio-vasculaire chez des patients coronariens dans le Sahel. East Mediterr Health J 13 (2007) 1-7
12. Ghannem H., and Hadj Fredj A. Epidemiology of hypertension and other cardiovascular disease risk factors in the urban population of Soussa, Tunisia. East Mediterr Health J 3 (1997) 472-479
13. Gharbi M., Belhani A., Aouidet A., Ben Rayanna C., Achour A., Nasraoui A., et al. Niveau des facteurs de risque cardiovasculaire dans la population de Cap-Bon, Tunisie. Rev Epidemiol Sante Publique 44 (1996) 125-132
14. Recensement de la population tunisienne 2004. Population, ménages et logements par unité administrative. Institut national de statistique. www.ins.nat.tn.
15. World Health Organization (WHO). The challenge of obesity in the WHO European Region and the strategies for response. Summary. In: Branca F, Nikogosian H and Lobstein T, editors. World Health Organization 2007.
16. Fédération française de cardiologie. Les facteurs de risque et comportements de prévention dans la population des trois registres de population 1994-1997 ; MONICA-France. Enquête Fédération française de cardiologie.
17. Tazi M.A., Abir-Khalil S., Chaouki N., Cherquaoui S., Lahmouz F., Srairi J., et al. Prevalence of the main cardiovascular risk factors in Morocco: results of a national survey, 2000. J Hypertens 21 (2003) 897-903
18. De Sereday M.S., Gonzalez C., Giorgini D., De Loredo L., Braguinsky J., Libman C., et al. Prevalence of diabetes, obesity, hypertension and hyperlipidemia in the central area of Argentina. Diabetes Metab 30 (2004) 335-339
19. Hajja I., Kotchen M.S., and Theodore A. Trends in prevalence awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 290 (2003) 199-206
20. Gu D., Reynolds K., Wu X., Chen J., Duan X., Muntner P., Huan G., et al. Prevalence, awareness, treatment and control of hypertension in China. Hypertension 40 (2002) 920-927
21. Jafar T., Levey A., Jafary F., White F., Gul A., Rahbar M., et al. Ethnic subgroup differences in hypertension in Pakistan. J Hyperten 21 (2003) 905-912
22. Stewart J., Kendrick D., and Nottingham Diabetes Blood Pressure Study Group. Setting and negotiating targets in people with type2 diabetes in primary care. Diabet Med 22 (2005) 683-687
23. Ajlouni K., Jaddou H., and Batieha A. Diabetes and impaired glucose tolerance in Jordan: prevalence and associated risk factors. J Intern Med 244 (1998) 317-323
24. Al-Moosa S., Allin S., Jemiai N., Al-Lawati J., and Mossialos E. Diabetes and urbanization in the Omani population: an analysis of national survey data. Popul Health Metr 4 (2006) 1-8
25. Rahman Al-Nuaim A. High prevalence of metabolic risk factors for cardiovascular diseases among Saudi population, aged 30 to 64 years. Int J Cardiol 62 (1997) 227-235
26. Abdella N., Al Arouj M., Al Nakhi A., Al Assoussi A., and Moussa M. Non-insulin dependent diabetes in Kuwait: prevalence rates and associated risk factors. Diabetes Res Clin Pract 42 (1998) 187-196
27. Castell C., Tresserras R., Serra J., Goday A., Lloveras G., and Salleras L. Prevalence of diabetes, in Catalonia (Spain): an oral glucose tolerance test-based population: study. Diabetes Res Clin Pract 43 (1999) 33-40
28. Gourdy P., Ruidavets J.B., Ferrieres J., Ducimetiere P., Amouvel P., Arveiler D., et al. MONICA study. Prevalence of type 2 diabetes and impaired fasting glucose in the middle-aged population of three French regions. The MONICA study 1995-1997. Diabetes Metab 27 (2001) 347-358
29. Sullivan P.W., Morrato E.H., Ghushchyan V., Wyatt H.R., and Hill J.O. Obesity, inactivity, and the prevalence of diabetes and diabetes-related cardiovascular comorbidities in the United States, 2000-2002. Diabetes Care 28 (2005) 1599-1603
30. Gu D., Gupta A., Muntner P., Shengshou H., Duan X., Chen J., et al. Prevalence of cardiovascular disease risk factor clustering among the adult population of China: results from the International Collaborative Study of Cardiovascular Disease in Asia (Inter Asia). Circulation 112 (2005) 658-665
31. Bouguerra R., Alberti H., Salem L.B., Rayana C.B., Atti J.E., Gaigi S., et al. The global diabetes pandemic: the Tunisian experience. Eur J Clin Nutr 61 (2007) 160-165
32. Harris M.I., Flegal K.M., Cowie C.C., Eberhardt M.S., Goldstein D.E., Little R.R., et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose, tolerance in US adults: The third National Health and Nutrition Examination Survey, 1988-1994. Diabetes care 21 (1998) 518-524
33. Wilson P.W., and Kannel W.B. Obesity, diabetes, and risk of cardiovascular disease in the elderly. Am J Geriatr Cardiol 11 (2002) 119-123
34. Abdul-Rahim H.F., Abu-Rmeileh N.M.E., Husseini A., Holmboe-Ottesen G., Jervell J., and Jertness E.B. Obesity and selected co-morbidities in an urban Palestinian population. Int J Obes 25 (2001) 1736-1740
35. Fouad M.F., Rastam S., Ward K.D., and Maziak W. Prevalence of obesity and its associated factors in Aleppo. Syria Prev Control 2 (2006) 85-94
36. Othaimeen A.I., Nozha M.A., and Osman A.K. Obesity: an emerging problem in Saudi Arabia. Analysis of data from the National Nutrition Survey. East Mediterr Health J 13 (2007) 441-448
37. Luo W., Morrison H., De Groh M., Waters C., DesMeules M., Jones-McLean A.M., et al. Le fardeau de l'obésité chez les adultes au Canada. Mal Chron Can 27 (2007) 147-157
38. Mokdad A.H., Ford E.S., Bowman B.A., Dietz W.H., Vinicor F., Bales V.S., et al. Prevalence of obesity, diabetes and obesity-related health risk factors, 2001. JAMA 289 (2003) 76-79
39. Lorenzo C., Williams K., Hunt K.J., and Haffner S.M. The National cholesterol education program-adult treatment Panel III, international diabetes federation, and world health organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes care 30 (2007) 8-13
40. Harzallah F., Alberti H., and Ben Khalifa F. The metabolic syndrome in an Arab population: a first look at the new International Diabetes Federation criteria. Diabet Med 23 (2006) 441-444
41. Rguibi M., and Belahsen R. Overweight and obesity among urban Sahraoui women of South Marocco. Ethn Dis 14 (2004) 542-547
42. Ford E.S., Giles W.H., and Dietz W.H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287 (2002) 356-359
43. Morales D.D., Punzalan F.E., Paz-Pacheco E., Sy Rody G., and Charmaine A. Duante for the National Nutrition And Health Survey (NNHES): 2003 Group. Metabolic syndrome in the Philippine general population: prevalence and risk for atherosclerotic cardiovascular disease and diabetes mellitus. Diab Vasc Dis Res 5 (2008) 36-43
44. Al-Lawati- J.A., Mohamed A.J., Al-Hinai H.Q., and Jousilahti P. Prevalence of the metabolic syndrome among Omani adults. Diabetes Care 26 (2003) 1781-1785
45. Balkau B., Vernay M., Mhamdi L., Novak M., Arondel D., Vol S., et al. The incidence and persistence of the National Cholesterol Education Program (NCEP) metabolic syndrome. The French DESIR study. Diabetes Metab 29 (2003) 526-532
46. Choi K.M., Kim S.M., Kim Y.E., Choi D.S., Baik S.H., and Lee J. Prevalence and cardiovascular disease risk of the metabolic syndrome using National Cholesterol Education Program and International Diabetes Federation definitions in the Korean population. Metab Clin Exp 56 (2007) 552-558
47. Gu D., Reynolds K., Wu X., Chen J., Duan X., Reynolds R.F., et al. Prevalence of the metabolic syndrome and overweight among adults in China. Lancet 365 (2005) 1398-1405
48. Hertz R.P., Unger A.N., and Ferrario C.M. Diabetes, hypertension, and dyslipidemia in Mexican Americans and Non-Hispanic Whites. Am J Prev Med 30 (2006) 103-110
49. Meaney E., Lara-Esqueda A., Ceballos-Reyes G.M., Asbun J., Vela A., Martinez-Marroquin Y., et al. Cardiovascular risk factors in the urban Mexican population: the FRIMEX study. Public Health 121 (2007) 378-384
50. Ghannem H., and Hadj Fredj A. Transition épidémiologique et facteurs de risque cardiovasculaire en Tunisie. Rev Epidemiol Sante Publique 45 (1997) 286-292
51. Institut national de statistique. Enquête budget et consommation et niveau de vie des ménages. Tunis. Institut national de statistique 1995; 127p.
52. Chaaba R., Hammami S., Attia N., Smaoui M., Masmoudi A.S., Mahjoub S., et al. Association of plasma cholesterol ester transfer protein activity and polymorphism with coronary artery disease extent in Tunisian type II diabetic patients. Clin Biochem 38 (2005) 373-378
53. Jemaa R., Rojbani H., Kallel A., Ben Ali S., Feki M., Chabrak S., et al. Association between the -2518G/A polymorphism in the monocyte chemoattractant protein-1 (MCP-1) gene and myocardial infarction in Tunisian patients. Clin Chim Acta 390 (2008) 122-125